Endometriosis Drugs Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Apr 2021
  • Pages: 120
  • SKU: IRTNTR70538

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The endometriosis drugs market has the potential to grow by USD 332.72 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 3.41%.

This endometriosis drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (hormone therapy and analgesics) and geography (North America, Europe, Asia, and the Rest of World (ROW)). The endometriosis drugs market report also offers information on several market vendors, including AbbVie Inc., AstraZeneca Plc, Bayer AG, Debiopharm International SA, Gedeon Richter Plc, Mayne Pharma Group Ltd., Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.

What will the Endometriosis Drugs Market Size be in 2021?


Browse TOC and LoE with selected illustrations and example pages of Endometriosis Drugs Market

 Get Your FREE Sample Now!

Endometriosis Drugs Market: Key Drivers and Trends

The rising focus on women's health is notably driving the endometriosis drugs market growth, although factors such as the suppressive nature of available therapies may impede the market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the endometriosis drugs industry get your FREE report sample now.

  • The rising concerns about women's health issues have prompted various organizations and government authorities, especially in developing countries, to conduct awareness programs on various women's health conditions and their diagnosis and treatment.
  • A few gynecological diseases and conditions such as endometriosis are becoming prevalent.
  • The Society of Obstetricians and Gynecologists of Canada, has developed and published a clinical practice guideline for the diagnosis and management of endometriosis.
  • The initiatives on women's health improvement are prompting women suffering from gynecological conditions such as endometriosis in availing diagnostic services, which, in turn, has increased the prescription rate of endometriosis drugs. 
  • The availability of patient assistance programs is one of the key endometriosis drugs market trends.
  • High-cost hormone-based therapeutics dominate the endometriosis drugs market because of the lack of effective drugs.
  • Vendors and organizations are offering patient-assistance programs such as co-pay models to reduce the cost burden on patients.
  • These programs will increase patient adherence to such drugs.
  • Vendors are further stressing on the development of therapeutics with high efficacy rates to cater to the unmet treatment needs for endometriosis and improve sales.

This endometriosis drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major Endometriosis Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:


  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Debiopharm International SA
  • Gedeon Richter Plc
  • Mayne Pharma Group Ltd.
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.


The endometriosis drugs market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the endometriosis drugs market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Endometriosis Drugs Market?


For more insights on the market share of various regions Request for a FREE sample now!

47% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for endometriosis drugs in North America. However, market growth in this region will be slower than the growth of the market in Asia.

The high prevalence of endometriosis will facilitate the endometriosis drugs market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Product Segments in the Endometriosis Drugs Market?


To gain further insights on the market contribution of various segments Request for a FREE sample

The endometriosis drugs market share growth by the hormone therapy segment will be significant during the forecast period. Hormone therapy is considered the most effective treatment for endometriosis as it can reduce or effectively eliminate the pain associated with the condition compared with analgesics. This factor will increase sales of medications that act on hormones associated with the condition. 

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the endometriosis drugs market size.



Request for a FREE sample

What are the Key Factors Covered in this Endometriosis Drugs Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive endometriosis drugs market growth during the next five years
  • Precise estimation of the endometriosis drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the endometriosis drugs industry across North America, Europe, Asia, and the Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of endometriosis drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>